Abstract
Aromatase catalyzes the conversion of androgens to estrogens through a series of monooxygenations to achieve the 19-desmolation and aromatization of the neutral steroid ring-A structure. We have separated two forms of aromatase, a major (P 2a) and a minor (P 3) form, from human term placenta through solubilization and chromatography. Partially purified aromatase in each form was immunoaffinity chromatographed to give a single band (SDS-PAGE) cytochrome P-450 of 55 kDa, utilizing a mouse monoclonal anti-human placental aromatase cytochrome P-450 IgG i (MAb3-2C2) which is capable of suppressing placental aromatase activity. The purified cytochrome P-450 showed specific aromatase activity of 25–30 nmol/min per mg with K m of 20–30 nM for androstenedione on reconstitution with NADPH-cyt P-450 reductase and dilauroyl l-α-phosphatidylcholine. This one step represents a higher than 100-fold purification with maintenance of the same K m. The stability analysis showed a half-life of more than 5 yr for solubilized aromatase and 2 months for the aromatase cytochrome P-450 on storage at − 90°C. Contrary to the recent claim that estrogen biosynthesis by reconstituted human placental cytochrome P-450 is by trans-diaxial 1α,2β-hydrogen elimination, all of our partially purified forms and reconstituted aromatase synthesized estrogens by cis-1β,2β-hydrogen elimination. Use of purified aromatase and [19- 3H 3, 4- 14C]androstenedione led us to discover a metabolic switching by aromatase to 2β-hydroxylation of androgen. Results of the MAb3-2C2 suppression of aromatase activity in different species and tissues inclucling human, baboons, horses, cows, pigs and rats indicated the presence of various isozymes of aromatase.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have